Evaheart, Inc. (Houston) announces it has received FDA approval to launch the EVAHEART 2 in a US clinical trial for Bridge-To-Transplant.
Site selection is currently ongoing, with enrollment anticipated by Q2, 2018.
EVI is hiring part-time remote-based Field Clinical Engineers in Miami, FL, Philadelphia, and Chicago.
Call 713.520.7979 Ext. 2 for further details.
Opening of a new Facility in Fukushima, Japan.
- Clinical Support
- AE Survey
- New Products R&D
Evaheart, Inc. enters agreement to utilize additional lab space for extended Medical Device R&D, Study preparation and Training seminars.
Evaheart, Inc. starts expanding to Europe and opens its first direct Representation:
Evaheart GmbH in Germany.